Surrozen (SRZN) Competitors $7.31 -1.16 (-13.70%) Closing price 04:00 PM EasternExtended Trading$7.25 -0.06 (-0.82%) As of 05:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SRZN vs. EXOZ, GNLX, COYA, SGMT, IVVD, MGNX, BDTX, CTNM, ENTX, and KYTXShould you be buying Surrozen stock or one of its competitors? The main competitors of Surrozen include Exozymes (EXOZ), Genelux (GNLX), Coya Therapeutics (COYA), Sagimet Biosciences (SGMT), Invivyd (IVVD), MacroGenics (MGNX), Black Diamond Therapeutics (BDTX), Contineum Therapeutics (CTNM), Entera Bio (ENTX), and Kyverna Therapeutics (KYTX). These companies are all part of the "pharmaceutical products" industry. Surrozen vs. Exozymes Genelux Coya Therapeutics Sagimet Biosciences Invivyd MacroGenics Black Diamond Therapeutics Contineum Therapeutics Entera Bio Kyverna Therapeutics Exozymes (NASDAQ:EXOZ) and Surrozen (NASDAQ:SRZN) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, valuation, community ranking, profitability, analyst recommendations, risk, dividends and earnings. Which has higher earnings & valuation, EXOZ or SRZN? Exozymes has higher earnings, but lower revenue than Surrozen. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioExozymesN/AN/AN/AN/AN/ASurrozen$11.64M5.38-$43.04M-$24.96-0.29 Is EXOZ or SRZN more profitable? Exozymes' return on equity of 0.00% beat Surrozen's return on equity.Company Net Margins Return on Equity Return on Assets ExozymesN/A N/A N/A Surrozen N/A -120.51%-54.68% Do analysts prefer EXOZ or SRZN? Surrozen has a consensus price target of $38.50, suggesting a potential upside of 426.68%. Given Surrozen's stronger consensus rating and higher probable upside, analysts clearly believe Surrozen is more favorable than Exozymes.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Exozymes 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Surrozen 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the MarketBeat Community favor EXOZ or SRZN? Surrozen received 7 more outperform votes than Exozymes when rated by MarketBeat users. CompanyUnderperformOutperformExozymesN/AN/ASurrozenOutperform Votes731.82% Underperform Votes1568.18% Do insiders and institutionals believe in EXOZ or SRZN? 66.6% of Surrozen shares are owned by institutional investors. 45.2% of Surrozen shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Does the media favor EXOZ or SRZN? In the previous week, Surrozen had 5 more articles in the media than Exozymes. MarketBeat recorded 5 mentions for Surrozen and 0 mentions for Exozymes. Exozymes' average media sentiment score of 0.67 beat Surrozen's score of -0.19 indicating that Exozymes is being referred to more favorably in the media. Company Overall Sentiment Exozymes Positive Surrozen Neutral SummarySurrozen beats Exozymes on 8 of the 11 factors compared between the two stocks. Get Surrozen News Delivered to You Automatically Sign up to receive the latest news and ratings for SRZN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SRZN vs. The Competition Export to ExcelMetricSurrozenBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$62.60M$2.93B$5.35B$8.38BDividend YieldN/A1.72%5.22%4.10%P/E Ratio-0.2930.5026.8419.71Price / Sales5.38400.15391.39116.98Price / CashN/A168.6838.2534.62Price / Book0.403.286.794.50Net Income-$43.04M-$72.17M$3.23B$248.18M7 Day Performance12.46%4.28%4.07%1.14%1 Month Performance-23.85%7.62%12.52%15.20%1 Year Performance-24.72%-28.15%16.83%6.56% Surrozen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SRZNSurrozen3.0023 of 5 stars$7.31-13.7%$38.50+426.7%-10.5%$62.60M$11.64M-0.2980Gap DownEXOZExozymesN/A$12.54-3.6%N/AN/A$104.93MN/A0.0029Gap UpHigh Trading VolumeGNLXGenelux1.2144 of 5 stars$2.78-6.1%$17.75+538.5%-36.0%$104.90M$8,000.00-2.9310High Trading VolumeCOYACoya Therapeutics2.0971 of 5 stars$6.14+1.5%$17.00+176.9%-34.1%$102.69M$3.55M-9.456Trending NewsAnalyst RevisionGap UpSGMTSagimet Biosciences1.5851 of 5 stars$3.31+1.5%$22.40+576.7%-27.6%$101.53M$2M-2.318IVVDInvivyd2.928 of 5 stars$0.84+29.7%$7.52+797.2%-64.0%$100.50M$25.38M-0.43100Earnings ReportGap DownMGNXMacroGenics3.5583 of 5 stars$1.59+11.2%$7.43+367.2%-63.1%$100.31M$148.34M-1.01430News CoveragePositive NewsAnalyst ForecastGap UpBDTXBlack Diamond Therapeutics3.3114 of 5 stars$1.75+6.7%$14.60+734.3%-55.7%$99.19MN/A-1.3290News CoveragePositive NewsCTNMContineum Therapeutics2.2039 of 5 stars$3.83-1.0%$23.75+520.1%-75.6%$99.09M$50M-0.7831Earnings ReportAnalyst ForecastENTXEntera Bio1.8091 of 5 stars$2.15flat$10.00+365.1%-10.4%$97.66M$223,000.00-8.2720News CoveragePositive NewsGap UpKYTXKyverna Therapeutics2.3955 of 5 stars$2.21+4.7%$18.33+729.6%-83.4%$95.51M$7.03M-0.6496News CoverageAnalyst RevisionGap Up Related Companies and Tools Related Companies EXOZ Competitors GNLX Competitors COYA Competitors SGMT Competitors IVVD Competitors MGNX Competitors BDTX Competitors CTNM Competitors ENTX Competitors KYTX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SRZN) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surrozen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Surrozen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SRZN Stock Free SRZN Stock Alerts